Mushrooms Causing ‘Tiny Human’ Hallucinations Lack Psychedelics – The Surprising Truth

Researchers have discovered that certain mushrooms causing hallucinations of tiny humans do not contain psilocybin or other known psychedelics, according to reporting by ScienceAlert. The findings challenge previous assumptions about how these specific fungi trigger visual distortions in the human brain.

The study focuses on the chemical composition of fungi that produce a specific type of hallucination known as Lilliputian hallucinations, where the user perceives small, human-like figures. While most psychedelic mushrooms rely on psilocybin to alter perception, these particular specimens lack those compounds entirely.

How do these mushrooms cause hallucinations without psychedelics?

The absence of psilocybin suggests a different biological mechanism is at work. According to ScienceAlert, the hallucinations are likely caused by other toxins or chemical compounds that affect the central nervous system differently than traditional psychedelics.

Psilocybin typically works by mimicking serotonin and binding to 5-HT2A receptors in the brain. Because these mushrooms do not contain these molecules, they do not follow the standard psychedelic pathway, which explains why the resulting imagery is so distinct and consistent.

What are the risks of non-psychedelic hallucinogens?

The distinction between psychedelic and non-psychedelic hallucinations is critical for safety. Psychedelics are generally characterized by a specific set of effects on consciousness, but toxins that cause hallucinations without those compounds can often be more dangerous.

Many mushrooms that cause hallucinations via non-psychedelic pathways are actually poisonous. These compounds can cause organ failure or severe neurological distress, whereas psilocybin-containing mushrooms are generally not lethal in isolation.

Why does this discovery matter for science?

This discovery provides a new data point for neuroscientists studying how the brain constructs visual reality. By identifying a compound that triggers a specific, repeatable image—like tiny humans—without using the serotonin system, researchers can better map the brain’s visual processing centers.

The findings suggest that there are multiple, independent chemical pathways to induce hallucinations. This contrast helps scientists distinguish between “classic” psychedelics and “deliriants,” which often produce more realistic and less controllable hallucinations.